Author

Senthilnathan Palaniyandi

university of Missouri - Cited by 1,305 - Cancer Biology

Biography

Dr. Senthilnathan Palaniyandi is from the Department of Medicine, Division of Hematology and Oncology, Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center Shreveport, Shreveport, have research interest in Hematology and Blood Marrow Transplantation Team
Title
Cited by
Year
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
L Schwab, L Goroncy, S Palaniyandi, S Gautam, A Triantafyllopoulou, ...Nature medicine 20 (6), 648-654, 2014201
263
2014
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
J Zhou, C Bi, JV Janakakumara, SC Liu, WJ Chng, KG Tay, LF Poon, ...Blood, The Journal of the American Society of Hematology 113 (17), 4052-4062, 2009200
188
2009
Therapeutic effect of paclitaxel and propolis on lipid peroxidation and antioxidant system in 7, 12 dimethyl benz (a) anthracene-induced breast cancer in female Sprague Dawley rats
R Padmavathi, P Senthilnathan, D Chodon, D SakthisekaranLife sciences 78 (24), 2820-2825, 2006200
134
2006
Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion
Z Xie, PF Choong, LF Poon, J Zhou, J Khng, VJ Jasinghe, S Palaniyandi, ...Cancer chemotherapy and pharmacology 62, 949-957, 2008200
71
2008
Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo (a) pyrene induced experimental lung cancer
P Senthilnathan, R Padmavathi, SM Banu, D SakthisekaranChemico-biological interactions 159 (3), 180-185, 2006200
57
2006
Therapeutic effect of propolis and paclitaxel on hepatic phase I and II enzymes and marker enzymes in dimethylbenz (a) anthracene-induced breast cancer in female rats
R Padmavathi, P Senthilnathan, D SakthisekaranComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2006200
55
2006
In vivo protective effect of crocetin on benzo(a)pyrene‐induced lung cancer in Swiss albino mice
V Magesh, K DurgaBhavani, P Senthilnathan, P Rajendran, ...Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2009200
53
2009
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
VJ Jasinghe, Z Xie, J Zhou, J Khng, LF Poon, P Senthilnathan, KB Glaser, ...Journal of hepatology 49 (6), 985-997, 2008200
46
2008
Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene‐induced experimental lung cancer
P Senthilnathan, R Padmavathi, V Magesh, D SakthisekaranCancer science 97 (7), 658-664, 2006200
43
2006
Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage
S Palaniyandi, Y Odaka, W Green, F Abreo, G Caldito, A De Benedetti, ...Gene therapy 18 (3), 275-282, 2011201
42
2011
Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer
G Sunavala‐Dossabhoy, S Palaniyandi, C Clark, CAO Nathan, FW Abreo, ...The Laryngoscope 121 (10), 2136-21, 2011201
41
2011
Modulation of TCA cycle enzymes and electron transport chain systems in experimental lung cancer
P Senthilnathan, R Padmavathi, V Magesh, D SakthisekaranLife sciences 78 (9), 1010-1014, 2006200
37
2006
Recombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomia
PST Shanmugam, RD Dayton, S Palaniyandi, F Abreo, G Caldito, ...Human gene therapy 24 (6), 604-612, 2013201
31
2013
Stabilization of Membrane Bound Enzyme Profiles and Lipid Peroxidation by Withania Somnifera Along with Paclitaxel on Benzo(a)pyrene Induced Experimental …
P Senthilnathan, R Padmavathi, V Magesh, D SakthisekaranMolecular and cellular biochemistry 292, 13-17, 2006200
24
2006
Microbiome: an emerging new frontier in graft-versus-host disease
R Kumari, S Palaniyandi, GC HildebrandtDigestive diseases and sciences 64, 669-677, 2019201
22
2019
Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation
SV Radhakrishnan, S Palaniyandi, G Mueller, S Miklos, M Hager, ...Biology of Blood and Marrow Transplantation 21 (1), 30-38, 2015201
22
2015
TAT-mediated delivery of Tousled protein to salivary glands protects against radiation-induced hypofunction
G Sunavala-Dossabhoy, S Palaniyandi, C Richardson, A De Benedetti, ...International Journal of Radiation Oncology* Biology* Physics 84 (1), 257-265, 20101
22
2012
Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from …
S Palaniyandi, SV Radhakrishnan, FJ Karlsson, KY Stokes, N Kittan, ...PLoS One 8 (4), e61841, 2013201
15
2013
Mast cells are mediators of fibrosis and effector cell recruitment in dermal chronic graft-vs.-host disease
E Strattan, S Palaniyandi, R Kumari, J Du, N Hakim, T Huang, MV Kesler, ...Frontiers in Immunology 10, 2470, 2019201
13
2019
Metabolic reprogramming—a new era how to prevent and treat graft versus host disease after allogeneic hematopoietic stem cell transplantation has begun
R Kumari, S Palaniyandi, GC HildebrandtFrontiers in Pharmacology 11, 588449, 2020202
12
2020

Referred From: https://scholar.google.com/citations?user=yQYQ264AAAAJ&hl=en

Cited by
Citations 1305
h-index 18
i10-index 22
Recommended Journals
Open Access Journals